Alpha Crest Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $931,569 - $1.04 Million	-3,402 Reduced 36.53%	5,910 $1.71 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $1.01 Million - $1.26 Million	-4,303 Reduced 31.6%	9,312 $2.62 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $4.45 Million - $5.25 Million	-20,120 Reduced 59.64%	13,615 $3.55 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $374,376 - $472,596	2,115 Added 6.69%	33,735 $7.41 Million
Q3 2021 Nov 10, 2021	SELL	$181.39 - $202.99 $505,715 - $565,936	-2,788 Reduced 8.1%	31,620 $5.74 Million
Q2 2021 Aug 12, 2021	BUY	$187.49 - $221.1 $3.38 Million - $3.98 Million	18,021 Added 109.97%	34,408 $6.94 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $2.46 Million - $2.87 Million	11,898 Added 265.05%	16,387 $3.52 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $149,875 - $199,889	724 Added 19.23%	4,489 $1.06 Million
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $523,826 - $621,051	-2,049 Reduced 35.24%	3,765 $1.03 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $462,684 - $606,981	2,052 Added 54.55%	5,814 $1.69 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $183,388 - $227,489	918 Added 32.28%	3,762 $895,000
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $2.19 Million - $2.94 Million	-13,138 Reduced 82.2%	2,844 $623,000
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $2.33 Million - $2.62 Million	14,007 Added 709.22%	15,982 $2.71 Million
Q2 2019 Aug 12, 2019	SELL	$164.61 - $190.37 $258,931 - $299,452	-1,573 Reduced 44.33%	1,975 $362,000
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $580,914 - $690,795	3,548 New	3,548 $653,000

Others Institutions Holding VRTX

# of Institutions

1,726

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$10.9 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.46 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.82 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.68 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account